المؤلفون: Schmitz RSJM; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands., van den Belt-Dusebout AW; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands., Clements K; National Health Service England, Birmingham, UK., Ren Y; Department of Biostatistics and Bioinformatics, Biostatistics Shared Resource Duke Cancer Institute, Durham, NC, USA., Cresta C; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands., Timbres J; School of Cancer and Pharmaceutical Science, King's College London, London, UK., Liu YH; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands., Byng D; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA., Lynch T; Department of Surgery, Duke Cancer Institute, Durham, NC, USA., Menegaz BA; Department of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA., Collyar D; Patient Advocates in Research, Danville, CA, USA., Hyslop T; Department of Biostatistics and Bioinformatics, Biostatistics Shared Resource Duke Cancer Institute, Durham, NC, USA., Thomas S; Department of Biostatistics and Bioinformatics, Biostatistics Shared Resource Duke Cancer Institute, Durham, NC, USA., Love JK; Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Schaapveld M; Division of Psycho-oncology and Epidemiology, Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Bhattacharjee P; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands., Ryser MD; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA.; Department of Mathematics, Duke University, Durham, NC, USA., Sawyer E; School of Cancer and Pharmaceutical Science, King's College London, London, UK., Hwang ES; Department of Surgery, Duke Cancer Institute, Durham, NC, USA., Thompson A; Department of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands.; Division of Diagnostic Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands., Lips EH; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, 1066 Amsterdam, Netherlands mk.schmidt@nki.nl.; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, Netherlands.

مؤلفون مشاركون: Grand Challenge PRECISION consortium

المصدر: BMJ (Clinical research ed.) [BMJ] 2023 Oct 30; Vol. 383, pp. e076022. Date of Electronic Publication: 2023 Oct 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology , Breast Neoplasms*/surgery , Carcinoma, Intraductal, Noninfiltrating*/epidemiology , Carcinoma, Intraductal, Noninfiltrating*/surgery, Female ; Humans ; Cohort Studies ; Mastectomy ; Mastectomy, Segmental ; Risk Factors ; Hormones ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/surgery

المؤلفون: Lamhamedi-Cherradi SE; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. SLamhamedi@mdanderson.org., Maitituoheti M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Menegaz BA; Department of Surgery, Breast surgical Oncology, Baylor College of Medicine, Houston, TX, 77030, USA., Krishnan S; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Vetter AM; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Camacho P; Texas Children's Cancer & Hematology Centers, Houston, TX, 77384, USA., Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Porter RW; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Ingram DR; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Ramamoorthy V; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Mohiuddin S; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., McCall D; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Truong DD; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Cuglievan B; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Futreal PA; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Velasco AR; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Anvar NE; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Utama B; Optical Microscopy Facility, Rice University, Houston, TX, 77030, USA., Titus M; Genitourinary Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lazar AJ; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang WL; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Rodriguez-Aguayo C; Experimental Therapeutics Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Ratan R; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Livingston JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Krai@mdanderson.org., MacLeod AR; Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA., Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hayes-Jordan A; Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, NC, 27599, USA., Ludwig JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jaludwig@mdanderson.org.

المصدر: Nature communications [Nat Commun] 2022 Jun 01; Vol. 13 (1), pp. 3057. Date of Electronic Publication: 2022 Jun 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Receptor Antagonists*/pharmacology , Desmoplastic Small Round Cell Tumor*/genetics , Receptors, Androgen*/genetics , Receptors, Androgen*/metabolism, Androgens ; Animals ; Cell Line, Tumor ; Humans ; Male ; Oligonucleotides, Antisense/pharmacology ; Xenograft Model Antitumor Assays

المؤلفون: Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kumar T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Megalios A; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Visser LL; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sheinman M; Division of Molecular Carcinogenesis, Oncode Institute and The Netherlands Cancer Institute, Amsterdam, The Netherlands., Fortunato A; School of Life Sciences, Arizona State University, Tempe, AZ, USA.; Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ, USA., Shah V; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Hoogstraat M; Division of Molecular Carcinogenesis, Oncode Institute and The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sei E; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mallo D; School of Life Sciences, Arizona State University, Tempe, AZ, USA.; Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ, USA., Roman-Escorza M; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Ahmed AA; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Xu M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., van den Belt-Dusebout AW; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Casasent AK; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Clements K; Screening Quality Assurance Service, Public Health England, London, UK., Davies HR; Early Cancer Unit, Hutchison/MRC Research Centre and Academic Department of Medical Genetics, Cambridge Biomedical Research Campus, University of Cambridge, Cambridge, UK., Fu L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Grigoriadis A; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Hardman TM; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., King LM; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Krete M; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kristel P; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Maaker M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Maley CC; Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ, USA., Marks JR; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Menegaz BA; Department of Surgery, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Mulder L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nieboer F; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nowinski S; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Pinder S; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Quist J; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Salinas-Souza C; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Schaapveld M; Division of Psychosocial research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Shaaban AM; Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK., Shami R; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Sridharan M; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stobart H; Independent Cancer Patients' Voice, London, UK., Collyar D; Patient Advocates in Research, Danville, CA, USA., Nik-Zainal S; Early Cancer Unit, Hutchison/MRC Research Centre and Academic Department of Medical Genetics, Cambridge Biomedical Research Campus, University of Cambridge, Cambridge, UK., Wessels LFA; Division of Molecular Carcinogenesis, Oncode Institute and The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, Delft, The Netherlands., Hwang ES; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Navin NE; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thompson AM; Department of Surgery, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Divisions of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Sawyer EJ; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, Guy's Cancer Centre, King's College London, London, UK. elinor.sawyer@kcl.ac.uk.

مؤلفون مشاركون: Grand Challenge PRECISION consortium

المصدر: Nature genetics [Nat Genet] 2022 Jun; Vol. 54 (6), pp. 850-860. Date of Electronic Publication: 2022 Jun 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Carcinoma, Ductal, Breast*/genetics , Carcinoma, Intraductal, Noninfiltrating*/genetics , Carcinoma, Intraductal, Noninfiltrating*/pathology, Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Female ; Genomics ; Humans ; Neoplasm Recurrence, Local/genetics

المؤلفون: Bhalla AD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Landers SM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Singh AK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Landry JP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yeagley MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Myerson GSB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Delgado-Baez CB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; University of Puerto Rico-Medical Science Campus, San Juan, PR, USA.; Partnership for Diversity, Sponsored by Women and Minority Faculty Inclusion, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dunnand S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Partnership for Diversity, Sponsored by Women and Minority Faculty Inclusion, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nguyen T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma X; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bolshakov S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Menegaz BA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mao X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCutcheon IE; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Slopis JM; Departments of Pediatrics and Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ludwig JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lev DC; Department of Surgery, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel., Rai K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Torres KE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ketorres@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ketorres@mdanderson.org.

المصدر: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2022 Jun; Vol. 102 (6), pp. 658-666. Date of Electronic Publication: 2022 Feb 28.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE

مواضيع طبية MeSH: Neurofibrosarcoma*/genetics , Sarcoma*/genetics , Sarcoma*/pathology , Soft Tissue Neoplasms*/genetics, Animals ; Humans ; Mice ; Models, Theoretical ; Mutation

المؤلفون: Lamhamedi-Cherradi SE; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mohiuddin S; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA., Mishra DK; Division of Thoracic Surgery, Department of Surgery, Houston Methodist Hospital, Houston, 77030, TX, USA., Krishnan S; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Velasco AR; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vetter AM; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pence K; Division of Thoracic Surgery, Department of Surgery, Houston Methodist Hospital, Houston, 77030, TX, USA., McCall D; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA., Truong DD; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cuglievan B; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA., Menegaz BA; Department of Surgery, Breast Surgical Oncology, Baylor College of Medicine, Houston, 77030, TX, USA., Utama B; Optical Microscopy Facility, Rice University, Houston, 77030, TX, USA., Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA., Molina ER; Bioengineering Department, Rice University, Houston, 77030, TX, USA., Zielinski RJ; Experimental Therapeutics Department, The University of Texas MD Anderson Cancer Center, Houston, 77005, TX, USA., Livingston JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA., Mikos AG; Bioengineering Department, Rice University, Houston, 77030, TX, USA., Kim MP; Division of Thoracic Surgery, Department of Surgery, Houston Methodist Hospital, Houston, 77030, TX, USA. mpkim@houstonmethodist.org., Ludwig JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jaludwig@mdanderson.org.

المصدر: Cancer gene therapy [Cancer Gene Ther] 2021 Dec; Vol. 28 (12), pp. 1325-1338. Date of Electronic Publication: 2021 Jan 06.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE

مواضيع طبية MeSH: Osteosarcoma/*genetics , Proto-Oncogene Proteins/*metabolism , Receptor Protein-Tyrosine Kinases/*metabolism , YAP-Signaling Proteins/*metabolism, Animals ; Cell Dedifferentiation ; Disease Models, Animal ; Humans ; Mice ; Neoplasm Metastasis ; Osteosarcoma/pathology ; Axl Receptor Tyrosine Kinase

المؤلفون: Amin HM; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Morani AC; Department of Nuclear Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Daw NC; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Subbiah V; Department of Investigational Cancer Therapeutics, 7Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Menegaz BA; Baylor College of Medicine, Department of Surgery, Breast Surgical Oncology, Houston, TX 77030, USA., Vishwamitra D; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Eskandari G; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., George B; Department of Hematopathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Benjamin RS; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Patel S; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Song J; Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lazar AJ; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang WL; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego (UCSD) Moores Cancer Center, San Diego, CA 92037, USA., Pappo A; Department of Pathology, St. Jude's Cancer Research Hospital, Memphis, TN 38105, USA., Anderson PM; Department of Pediatric Oncology, Cleveland Clinic, OH 44195, USA., Schwartz GK; Division of Hematology & Oncology, Columbia University Medical Center, New York, NY 10032, USA., Araujo D; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cuglievan B; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ratan R; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., McCall D; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mohiuddin S; Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Livingston JA; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Molina ER; Baylor College of Medicine, Department of Surgery, Breast Surgical Oncology, Houston, TX 77030, USA., Naing A; Department of Investigational Cancer Therapeutics, 7Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ludwig JA; Department of Sarcoma Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

المصدر: Cancers [Cancers (Basel)] 2020 Jul 02; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Molina ER, Chim LK, Salazar MC, Koons GL, Menegaz BA; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, United States., Ruiz-Velasco A; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, United States., Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, United States., Vetter AM; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, United States., Satish T, Cuglievan B; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, United States., Smoak MM, Scott DW, Ludwig JA; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas 77030, United States., Mikos AG

المصدر: ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2020 Jan 13; Vol. 6 (1), pp. 539-552. Date of Electronic Publication: 2019 Dec 13.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101654670 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-9878 (Electronic) Linking ISSN: 23739878 NLM ISO Abbreviation: ACS Biomater Sci Eng Subsets: MEDLINE

مواضيع طبية MeSH: Bone Neoplasms*/drug therapy , Sarcoma, Ewing*/drug therapy, Bone and Bones ; Extracellular Matrix ; Humans ; Tissue Engineering ; Tumor Microenvironment

المؤلفون: Molina ER; Department of Bioengineering, Rice University, Houston, TX, United States., Chim LK; Department of Bioengineering, Rice University, Houston, TX, United States., Salazar MC; Department of Bioengineering, Rice University, Houston, TX, United States., Mehta SM; Department of Applied Physics, Rice University, Houston, TX, United States., Menegaz BA; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Satish T; Department of Bioengineering, Rice University, Houston, TX, United States., Mohiuddin S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., McCall D; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Zaske AM; The University of Texas Health Science Center at Houston, Houston, TX, United States., Cuglievan B; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Lazar AJ; Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Scott DW; Department of Statistics, Rice University, Houston, TX, United States., Grande-Allen JK; Department of Bioengineering, Rice University, Houston, TX, United States., Ludwig JA; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Mikos AG; Department of Bioengineering, Rice University, Houston, TX, United States. Electronic address: mikos@rice.edu.

المصدر: Acta biomaterialia [Acta Biomater] 2019 Dec; Vol. 100, pp. 38-51. Date of Electronic Publication: 2019 Sep 19.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568 (Electronic) Linking ISSN: 17427061 NLM ISO Abbreviation: Acta Biomater Subsets: MEDLINE

مواضيع طبية MeSH: Mechanical Phenomena* , Mechanotransduction, Cellular* , Models, Biological*, Adaptor Proteins, Signal Transducing/*metabolism , Osteosarcoma/*metabolism , Receptor, IGF Type 1/*metabolism , Trans-Activators/*metabolism , Transcription Factors/*metabolism, Bone Neoplasms/metabolism ; Cell Line, Tumor ; Down-Regulation ; Elastic Modulus ; Gelatin/chemistry ; Humans ; Phenotype ; Polyesters/chemistry ; SOXB1 Transcription Factors/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Tensile Strength ; Transcriptional Coactivator with PDZ-Binding Motif Proteins ; Tumor Microenvironment ; Up-Regulation ; YAP-Signaling Proteins

المؤلفون: Puerto-Camacho P; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Amaral AT; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Lamhamedi-Cherradi SE; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Menegaz BA; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Castillo-Ecija H; Institut de Recerca Sant Joan de Déu, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Spain., Ordóñez JL; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Domínguez S; Oncomatryx, Derio, Bilbao, Spain., Jordan-Perez C; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Diaz-Martin J; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Romero-Pérez L; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Lopez-Alvarez M; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Civantos-Jubera G; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Robles-Frías MJ; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Biscuola M; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain., Ferrer C; Oncomatryx, Derio, Bilbao, Spain., Mora J; Institut de Recerca Sant Joan de Déu, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Spain., Cuglievan B; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Schadler K; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas., Seifert O; IZI, University of Stuttgart, Germany., Kontermann R; IZI, University of Stuttgart, Germany., Pfizenmaier K; IZI, University of Stuttgart, Germany., Simón L; Oncomatryx, Derio, Bilbao, Spain., Fabre M; Oncomatryx, Derio, Bilbao, Spain., Carcaboso ÁM; Institut de Recerca Sant Joan de Déu, Pediatric Hematology and Oncology, Hospital Sant Joan de Déu Barcelona, Spain., Ludwig JA; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. enrique.alava.sspa@juntadeandalucia.es jaludwig@mdanderson.org., de Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain. enrique.alava.sspa@juntadeandalucia.es jaludwig@mdanderson.org.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Apr 01; Vol. 25 (7), pp. 2228-2240. Date of Electronic Publication: 2018 Nov 12.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*pharmacology , Bone Neoplasms/*metabolism , Endoglin/*antagonists & inhibitors , Immunoconjugates/*pharmacology , Sarcoma, Ewing/*metabolism, Animals ; Bone Neoplasms/drug therapy ; Bone Neoplasms/pathology ; Cell Line ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Gene Expression ; Humans ; Matrix Metalloproteinase 14/genetics ; Matrix Metalloproteinase 14/metabolism ; Mice ; Molecular Targeted Therapy ; Precision Medicine ; Sarcoma, Ewing/drug therapy ; Sarcoma, Ewing/pathology ; Xenograft Model Antitumor Assays

المؤلفون: Subbiah V; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. jaludwig@mdanderson.org vsubbiah@mdanderson.org., Lamhamedi-Cherradi SE; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cuglievan B; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Menegaz BA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Camacho P; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huh W; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ramamoorthy V; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Anderson PM; Department of Pediatric Hematology/Oncology/BMT, Cleveland Clinic Foundation, Cleveland, Ohio., Pollock RE; Division of Surgical Oncology, Ohio State University, Columbus, Ohio., Lev DC; Division of Surgical Oncology, Ohio State University, Columbus, Ohio., Qiao W; Division of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., McAleer MF; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Benjamin RS; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Herzog CE; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Feig BW; Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazar AJ; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hayes-Jordan A; Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ludwig JA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. jaludwig@mdanderson.org vsubbiah@mdanderson.org.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Oct 01; Vol. 24 (19), pp. 4865-4873. Date of Electronic Publication: 2018 Jun 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cytoreduction Surgical Procedures*, Desmoplastic Small Round Cell Tumor/*drug therapy , Sarcoma, Ewing/*drug therapy, Adult ; Combined Modality Therapy ; Desmoplastic Small Round Cell Tumor/genetics ; Desmoplastic Small Round Cell Tumor/pathology ; Desmoplastic Small Round Cell Tumor/surgery ; Disease-Free Survival ; Female ; Humans ; Male ; RNA-Binding Protein EWS/genetics ; Sarcoma, Ewing/genetics ; Sarcoma, Ewing/pathology ; Sarcoma, Ewing/surgery ; Young Adult